tiprankstipranks
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
India Market

Nectar Lifesciences Ltd. (NECLIFE) Financial Statements

Compare
0 Followers

Nectar Lifesciences Ltd. Financial Overview

Nectar Lifesciences Ltd.'s market cap is currently ₹6.55B. The company's EPS TTM is ₹0.758; its P/E ratio is 38.54; Nectar Lifesciences Ltd. is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 16.84B₹ 15.24B₹ 16.69B₹ 15.43B₹ 23.66B
Gross Profit₹ 4.82B₹ 3.64B₹ 2.99B₹ 2.58B₹ 3.69B
Operating Income₹ 3.89B₹ -51.73M₹ 1.02B₹ 499.91M₹ 1.59B
EBITDA₹ 1.69B₹ 539.47M₹ 1.59B₹ 1.10B₹ 2.20B
Net Income₹ 49.95M₹ -241.83M₹ 250.47M₹ -732.64M₹ 317.89M
Balance Sheet
Cash & Short-Term Investments₹ 203.01M₹ 596.53M₹ 182.35M₹ 259.58M₹ 214.22M
Total Assets₹ 21.91B₹ 21.89B₹ 23.91B₹ 24.71B₹ 26.33B
Total Debt₹ 6.36B₹ 7.54B₹ 8.60B₹ 9.03B₹ 7.79B
Net Debt₹ 6.16B₹ 7.36B₹ 8.42B₹ 8.78B₹ 7.58B
Total Liabilities₹ 11.22B₹ 11.25B₹ 13.03B₹ 14.09B₹ 14.97B
Stockholders' Equity₹ 10.69B₹ 10.65B₹ 10.88B₹ 10.62B₹ 11.36B
Cash Flow
Free Cash Flow₹ 1.95B₹ 1.04B₹ 700.35M₹ -98.62M₹ 2.30B
Operating Cash Flow₹ 2.25B₹ 1.34B₹ 950.05M₹ 213.79M₹ 2.85B
Investing Cash Flow₹ -170.25M₹ 517.04M₹ 166.44M₹ -286.24M₹ -331.28M
Financing Cash Flow₹ -2.05B₹ -1.86B₹ -1.19B₹ 114.90M₹ -2.52B
Currency in INR

Nectar Lifesciences Ltd. Earnings and Revenue History

Nectar Lifesciences Ltd. Debt to Assets

Nectar Lifesciences Ltd. Cash Flow

Nectar Lifesciences Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis